Skip to the page

Data / Drug companies / Levothyroxine sodium

Levothyroxine sodium: 44 companies and 565 products in the FDA NDC directory

Levothyroxine sodium is listed in the FDA National Drug Code Directory by 44 companies, with 565 products in commercial distribution. 321 of the products (56.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule; solution, and the newest product started marketing on July 6, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
44
Products
565
Generic (ANDA) products
321 (56.8%)
Application numbers
19
Routes
Oral, Intravenous
Brand names
Tirosint, Tirosint Sol, Synthroid, Unithroid, Levoxyl, Thyquidity
openFDA record search
api.fda.gov

Companies that list levothyroxine sodium

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions74tabletGeneric drugs (ANDA)April 8, 2025
Bryant Ranch Prepack46tabletGeneric drugs (ANDA)December 21, 2022
Northwind Health Company, LLC35tabletGeneric drugs (ANDA)March 30, 2023
Ibsa Pharma Inc.30capsule; solutionNew drug applications (NDA)March 1, 2023
Preferred Pharmaceuticals Inc.28tabletGeneric drugs (ANDA)April 20, 2026
NuCare Pharmaceuticals,Inc.18tabletGeneric drugs (ANDA)April 8, 2025
Proficient Rx LP17tabletNew drug applications (NDA)December 10, 2020
Alvogen Inc.14tabletNew drug applications (NDA)May 7, 2019
Cardinal Health 107, LLC13tabletGeneric drugs (ANDA)May 2, 2019
Coupler LLC13tabletGeneric drugs (ANDA)July 6, 2026
Direct_Rx13tabletNew drug applications (NDA)January 9, 2025
Remedyrepack Inc.13tabletGeneric drugs (ANDA)August 13, 2025
AbbVie Inc.12tabletNew drug applications (NDA)July 24, 2002
Accord Healthcare Inc.12tabletGeneric drugs (ANDA)December 10, 2020
Amneal Pharmaceuticals LLC12tabletNew drug applications (NDA)July 3, 2014
Amneal Pharmaceuticals NY LLC12tabletAuthorized generics (NDA)October 1, 2007
Asclemed USA Inc.12tabletGeneric drugs (ANDA)December 10, 2020
Camber Pharmaceuticals, Inc.12tabletGeneric drugs (ANDA)January 18, 2023
Lannett Company, Inc.12tabletAuthorized generics (NDA)August 3, 2020
Lupin Pharmaceuticals, Inc.12tabletGeneric drugs (ANDA)May 2, 2019
Macleods Pharmaceuticals Limited12tabletGeneric drugs (ANDA)December 21, 2022
Proficient Rx LP12tabletGeneric drugs (ANDA)September 21, 2022
XLCare Pharmaceuticals, Inc.12tabletGeneric drugs (ANDA)January 18, 2023
Yaral Pharma Inc.12capsuleAuthorized generics (NDA)March 1, 2023
American Health Packaging11tabletGeneric drugs (ANDA)January 5, 2021
NorthStar RxLLC11tabletGeneric drugs (ANDA)April 8, 2025
Pfizer Laboratories Div Pfizer Inc11tabletNew drug applications (NDA)May 25, 2001
NCS HealthCare of Ky, LLC DBA Vangard Labs10tabletNew drug applications (NDA)October 1, 2007
Bryant Ranch Prepack9tabletAuthorized generics (NDA)August 3, 2020
Major Pharmaceuticals9tabletGeneric drugs (ANDA)May 2, 2019
Bryant Ranch Prepack7tabletAuthorized generics (NDA)August 3, 2020
Mylan Institutional Inc.6tabletGeneric drugs (ANDA)February 26, 2007
Aurobindo Pharma Limited5tabletGeneric drugs (ANDA)July 16, 2024
Fresenius Kabi USA, LLC5injection, solutionNew drug applications (NDA)May 29, 2018
Teva Pharmaceuticals, Inc.5tabletGeneric drugs (ANDA)September 21, 2022
Mylan Institutional Inc.4tabletGeneric drugs (ANDA)January 14, 2019
Redpharm Drug3tabletGeneric drugs (ANDA)December 10, 2020
Zydus Pharmaceuticals USA Inc.3injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2024
PD-Rx Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)December 10, 2020
Piramal Critical Care Inc2injectionGeneric drugs (ANDA)October 1, 2022
Hikma Pharmaceuticals USA Inc.1injection, solutionNew drug applications (NDA)November 15, 2022
Northwind Health Company, LLC1tabletGeneric drugs (ANDA)July 5, 2023
Oliva Therapeutics, LLC1solutionNew drug applications (NDA)July 1, 2025
Zydus Lifesciences Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2024

Dosage forms

Dosage formProductsShare
Tablet51090.3%
Capsule274.8%
Solution162.8%
Injection, solution61.1%
Injection, powder, lyophilized, for solution40.7%
Injection20.4%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)32156.8%
New drug applications (NDA)16128.5%
Authorized generics (NDA)8314.7%

Pharmacologic classes

ClassProducts
l-Thyroxine565

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.